摘要
药品是中国重要的卫生资源。尽管上市前药品研究已受到相当重视,但对上市后药品的实际问题关注较少。合理使用和分配上市后药品资源是中国的决策者面临的主要问题之一。经济学评价作为优化分配和使用药品的有效工具现已得到公认。本文介绍了上市后药物的经济学评价方法与原则。上市后药物的经济学评价根据证据的有效性和数量分为三种情况,并相应地采取不同的研究方法。但上市后药物经济学评价方法应采取标准路径。此外,本文还介绍了建立经济学评价框架和评价经济学证据的方法,特别是针对同类药物的评价方法。
Medichie is a very important health resource in Chins Although numerous efforts are paid to pre-marketed medicines, little is done to address practical problems in marketed medicines. The rational use and allocation of marketed medicines remain a major concern for decision-makers in China. It has been recognized that economic evaluation is an efficient tool for priotiting the choice, and optimizing the use of medicines. This paper has explored the methods and principles for conducting econonfic evaluathm of marketed medicines Different strategies will be adopted for economic evidence for marketed medicines in terms of adequacy and suficiency. However, a standard study pathway should be applied in economic evaluanon of marketed medicines. Besides, the aspects for developing economic framework and the methods for reviewing existing economic evidence are also introduced in this paper, particularly, for marketed medicines within the same therapeutic group.
出处
《中国循证医学杂志》
CSCD
2005年第12期944-949,共6页
Chinese Journal of Evidence-based Medicine
关键词
经济学评价
成本-效果
药物评价
循证医学
Economic evaluation
Cost-benefit
Drug evaluation
Evidence-based medicine
